Efficacy and Safety of the Endobarrier Gastrointestinal Liner on Obesity and Type 2 Diabetes: A Two Center Prospective Study

被引：0
|
作者：
Alhassani, Abdulla [1 ]
Nunes, Isa [1 ]
Alawadhi, Sameer [2 ]
Taha, Hala A. [1 ]
Alnuaimi, Huda A. [1 ]
Alketbi, Mufleh [1 ]
Bamakhrama, Khalid [2 ]
Alzaabi, Mohammed [1 ]
机构：
[1] Zayed Mil Hosp, Gastroenterol, Abu Dhabi, U Arab Emirates
[2] Rashid Hosp, Gastroenterol, Dubai, U Arab Emirates
来源：
GASTROINTESTINAL ENDOSCOPY | 2017年 / 85卷 / 05期
关键词：
D O I：
10.1016/j.gie.2017.03.632
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa2018
引用
收藏
页码：AB279 / AB279
页数：1
相关论文
共 50 条
  • [1] Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis
    Rohde, U.
    Hedback, N.
    Gluud, L. L.
    Vilsboll, T.
    Knop, F. K.
    [J]. DIABETES OBESITY & METABOLISM, 2016, 18 (03): : 300 - 305
  • [2] Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: protocol for systematic review and meta-analysis of clinical studies
    Rohde, Ulrich
    Hedback, Nora
    Gluud, Lise L.
    Vilsboll, Tina
    Knop, Filip K.
    [J]. BMJ OPEN, 2013, 3 (09):
  • [3] The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetes
    Rohde, Ulrich
    Federspiel, Cecilie A.
    Vilmann, Peter
    Langholz, Ebbe
    Friis, Steffen U.
    Krakauer, Martin
    Rehfeld, Jens F.
    Holst, Jens J.
    Vilsboll, Tina
    Knop, Filip K.
    [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (02): : 189 - 199
  • [4] Endobarrier® gastrointestinal liner in obese subjects with type 2 diabetes - Sustainable effects on insulin sensitivity after explantation
    Pferschy, Peter
    Tripolt, Norbert
    Url, Jasmin
    Aberer, Felix
    Hoegenauer, Christoph
    Schreiber, Florian
    Eherer, Andreas
    Sourij, Caren
    Svehlikova, Eva
    Obermayer, Anna-Maria
    Stadlbauer, Vanessa
    Sourij, Harald
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 374 - 374
  • [5] Endobarrier® Gastrointestinal Liner in Obese Subjects with Type 2 Diabetes-Short- and Midterm Effects on Glucose Metabolism
    Tripolt, Norbert J.
    Aberer, Felix
    Url, Jasmin
    Pferschy, Peter N.
    Hogenauer, Christoph
    Schreiber, Florian
    Eherer, Andreas
    Svehlikova, Eva
    Sourij, Caren
    Obermayer, Anna M.
    Stadlbauer, Vanessa
    Sourij, Harald
    [J]. DIABETES, 2018, 67
  • [6] The duodenal-jejunal bypass sleeve (EndoBarrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes
    Patel, Shaneel R. H.
    Hakim, David
    Mason, John
    Hakim, Nadey
    [J]. SURGERY FOR OBESITY AND RELATED DISEASES, 2013, 9 (03) : 482 - 484
  • [7] ENDOBARRIER DUODENO-JEJUNAL BYPASS LINER (ENDOSCOPIC TREATMENT OF TYPE II DIABETES AND OBESITY)
    Frydenberg, Harry
    [J]. OBESITY SURGERY, 2013, 23 (06) : 829 - 829
  • [8] ENDOBARRIER® : A SAFE AND EFFECTIVE NOVEL TREATMENT FOR OBESITY AND TYPE 2 DIABETES?
    Mohanaruban, A.
    Patel, N.
    Ashrafian, H.
    Stoenchev, K.
    Le Roux, C.
    Penney, N.
    Kelly, J.
    Byrne, J.
    Hopkins, J.
    Mason, J.
    Teare, J.
    [J]. GUT, 2017, 66 : A205 - A205
  • [9] EndoBarrier®: a Safe and Effective Novel Treatment for Obesity and Type 2 Diabetes?
    Nisha Patel
    Aruchuna Mohanaruban
    Hutan Ashrafian
    Carel Le Roux
    James Byrne
    John Mason
    James Hopkins
    Jamie Kelly
    Julian Teare
    [J]. Obesity Surgery, 2018, 28 : 1980 - 1989
  • [10] The Duodenal-Jejunal Bypass Sleeve (EndoBarrier Gastrointestinal Liner) for Weight Loss and Treatment of Type II Diabetes
    Patel, Shaneel R.
    Mason, John
    Hakim, Nadey
    [J]. INDIAN JOURNAL OF SURGERY, 2012, 74 (04) : 275 - 277
12345